XML 71 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' DEFICIT (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Performance-based Restricted Stock Units Vesting Conditions The following table presents additional information relating to each MSU award:
Share Price Goal
Incremental Units
Tranche Cumulative Units
December 31, 2024 Vesting:
$3.14 144,041 144,041 
$5.00 144,041 288,082 
$8.00 144,041 432,123 
$10.00 144,041 576,164 
$12.00 144,041 720,205 
$14.00 144,041 864,246 
December 31, 2025 Vesting:
$3.14 144,041 144,041 
$5.00 144,041 288,082 
$8.00 144,041 432,123 
$10.00 144,041 576,164 
$12.00 144,041 720,205 
$14.00 144,041 864,246 
December 31, 2026 Vesting:
$3.14 144,041 144,041 
$5.00 144,041 288,082 
$8.00 144,041 432,123 
$10.00 144,041 576,164 
$12.00 144,041 720,205 
$14.00 144,041 864,246 
Schedule of Share-Based Payment Arrangement Option Activity
A summary of stock option activity for the year ended December 31, 2024, is as follows (amounts in thousands, except per share amounts):
 Number of
Shares		Weighted-
Average Exercise
Price		Weighted-Average
Remaining
Contractual Term
(in years)		Aggregate
Intrinsic
Value
Options outstanding - December 31, 2023
22,575 8.88 6.9$— 
Cancellation of common stock in connection with emergence
(22,575)8.88 
Issuance of new common stock in connection with emergence
2,257 88.84 
Options outstanding - Effective Date
2,257 88.84 
Granted— — 
Exercised
— — 
Forfeited or cancelled
(1,888)94.09 
        Expired
— — 
Options outstanding - December 31, 2024
369 $62.12 3.6$372 
Options expected to vest as of December 31, 2024
— $127.39 3.2$— 
Options exercisable as of December 31, 2024
369 $61.61 3.6$372 
Schedule of Restricted Stock Units Activity
A summary of RSU and MSU activity for the year ended December 31, 2024, is as follows (amounts in thousands, except per share amounts):
Restricted Stock Units
Market Condition Restricted Stock Units
Number of
Shares		Weighted-Average
Grant Date Fair
Value		Number of
Shares		Weighted-Average
Grant Date Fair
Value
Unvested - December 31, 2023
38,358 2.69 — — 
Cancellation of common stock in connection with emergence
(38,358)2.69 — — 
Issuance of new common stock in connection with emergence
3,83626.93 — — 
Unvested - Effective Date
3,836 26.93 — — 
Granted
20,914 6.70 2,843 6.07 
Vested
(3,857)15.71 (879)6.11 
Forfeited
(2,552)16.42 (236)3.99 
Unvested - December 31, 2024
18,341 $7.68 1,728 $6.11 
Schedule of Share-based Compensation Arrangements by Share-based Payment Award
Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022, is included in the Company’s Consolidated Statements of Operations as follows (in thousands):

Year Ended December 31,
202420232022
Cost of revenue$7,950 $5,050 $25,779 
Research and development2,810 1,337 22,093 
Sales and marketing5,846 4,929 9,401 
General and administrative
35,318 47,576 125,621 
Stock-based compensation expense, net of amounts capitalized
51,924 58,892 182,894 
Capitalized stock-based compensation1
487 — — 
Total stock-based compensation cost
$52,411 $58,892 $182,894 
1 Represents the amounts of stock-based compensation capitalized to property, plant, and equipment.